Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21679 | 409 | 27.7 | 49% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
3092 | 2 | POSTOPERATIVE SEPTIC COMPLICATIONS//TREATMENT RELATED TOXICITIES//MIGRATION STIMULATION FACTOR | 2357 |
21679 | 1 | POSTOPERATIVE SEPTIC COMPLICATIONS//TREATMENT RELATED TOXICITIES//BOVINE BETALACTOGLOBULIN | 409 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | POSTOPERATIVE SEPTIC COMPLICATIONS | authKW | 266632 | 1% | 71% | 5 |
2 | TREATMENT RELATED TOXICITIES | authKW | 223973 | 1% | 100% | 3 |
3 | BOVINE BETALACTOGLOBULIN | authKW | 149315 | 0% | 100% | 2 |
4 | MUCOSAL ANTIGENS | authKW | 149315 | 0% | 100% | 2 |
5 | CITOFLUORIMETRIA TER IE CELLULARI | address | 99542 | 0% | 67% | 2 |
6 | ACTIVE ROSETTE FORMING CELLS | authKW | 74658 | 0% | 100% | 1 |
7 | ADJUVANT BREAST CANCER CHEMOTHERAPY | authKW | 74658 | 0% | 100% | 1 |
8 | AIDS HIV MONOCYTE MACROPHAGE IL1 IL6 TUMOR TNF | authKW | 74658 | 0% | 100% | 1 |
9 | ANTIBODY FUNCTIONAL AFFINITY | authKW | 74658 | 0% | 100% | 1 |
10 | BONE UPTAKE OF GA 67 | authKW | 74658 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5357 | 59% | 0% | 240 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 476 | 14% | 0% | 58 |
3 | Obstetrics & Gynecology | 457 | 11% | 0% | 44 |
4 | Immunology | 191 | 12% | 0% | 49 |
5 | Surgery | 53 | 8% | 0% | 34 |
6 | Medicine, Research & Experimental | 40 | 5% | 0% | 20 |
7 | Medicine, General & Internal | 29 | 6% | 0% | 23 |
8 | Medical Laboratory Technology | 22 | 1% | 0% | 6 |
9 | Otorhinolaryngology | 15 | 2% | 0% | 7 |
10 | Allergy | 11 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CITOFLUORIMETRIA TER IE CELLULARI | 99542 | 0% | 67% | 2 |
2 | BORDET MICROBIOL | 74658 | 0% | 100% | 1 |
3 | BRUGMAN HOSP IMMUNOL | 74658 | 0% | 100% | 1 |
4 | COREVIH POITOU CHARENTES | 74658 | 0% | 100% | 1 |
5 | DAKO CZECH REPUBL | 74658 | 0% | 100% | 1 |
6 | EQUIPE RECH CANC | 74658 | 0% | 100% | 1 |
7 | GYNECOL OSTETR CLIN | 74658 | 0% | 100% | 1 |
8 | HOP ERASME CHEST | 74658 | 0% | 100% | 1 |
9 | ONCOL NUCL MED CLIN | 74658 | 0% | 100% | 1 |
10 | POLE MED INTERNE REANIMAT | 74658 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA RADIOLOGICA ONCOLOGY | 28201 | 3% | 3% | 13 |
2 | CLINICIAN | 6785 | 0% | 9% | 1 |
3 | GYNECOLOGIC ONCOLOGY | 4084 | 6% | 0% | 25 |
4 | ARCHIV FUR JAPANISCHE CHIRURGIE | 2984 | 0% | 4% | 1 |
5 | NEOPLASMA | 2901 | 3% | 0% | 11 |
6 | ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY | 2761 | 0% | 2% | 2 |
7 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 2526 | 2% | 0% | 8 |
8 | CANCER | 2414 | 7% | 0% | 30 |
9 | JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY | 1672 | 1% | 0% | 5 |
10 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1378 | 4% | 0% | 18 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KAPOOR, V , KHUDANYAN, A , DE LA PUENTE, P , CAMPIAN, J , HALLAHAN, DE , AZAB, AK , THOTALA, D , (2015) STEM CELL TRANSFUSION RESTORES IMMUNE FUNCTION IN RADIATION-INDUCED LYMPHOPENIC C57BL/6 MICE.CANCER RESEARCH. VOL. 75. ISSUE 17. P. 3442 -3445 | 7 | 100% | 0 |
2 | PILLAI, R , BALARAM, P , NAIR, BS , HAREENDRAN, NK , PADMANABHAN, TK , NAIR, MK , (1991) LYMPHOCYTE SUBSET DISTRIBUTION AFTER RADIATION-THERAPY FOR CANCER OF THE UTERINE CERVIX - POSSIBLE PROGNOSTIC IMPLICATIONS AND CORRELATION WITH DISEASE COURSE.CANCER. VOL. 67. ISSUE 8. P. 2071-2078 | 14 | 100% | 15 |
3 | WU, ES , ODUYEBO, T , COBB, LP , CHOLAKIAN, D , KONG, XR , FADER, AN , LEVINSON, KL , TANNER, EJ , STONE, RL , PIOTROWSKI, A , ET AL (2016) LYMPHOPENIA AND ITS ASSOCIATION WITH SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER.GYNECOLOGIC ONCOLOGY. VOL. 140. ISSUE 1. P. 76 -82 | 12 | 44% | 3 |
4 | VUCKOVICDEKIC, L , STANOJEVICBAKIC, N , DURBABA, M , DORDEVIC, D , (1996) DYNAMICS OF SPONTANEOUS RECOVERY FROM RADIOTHERAPY-INDUCED CELLULAR IMMUNODEPRESSION IN CERVICAL CANCER PATIENTS: A THREE-YEAR FOLLOW-UP.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 15. ISSUE 2. P. 185-190 | 16 | 70% | 2 |
5 | JURANIC, Z , VUCKOVICDEKIC, L , DURBABA, M , (1994) IMMUNE REACTIVE PROTEINS IN PATIENTS IRRADIATED FOR CERVICAL-CANCER - ONE-YEAR FOLLOW-UP.NEOPLASMA. VOL. 41. ISSUE 4. P. 225-228 | 9 | 90% | 1 |
6 | ZARYBNICKA, L , VAVROVA, J , HAVELEK, R , TICHY, A , PEJCHAL, J , SINKOROVA, Z , (2013) LYMPHOCYTE SUBSETS AND THEIR H2AX PHOSPHORYLATION IN RESPONSE TO IN VIVO IRRADIATION IN RATS.INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. VOL. 89. ISSUE 2. P. 110-117 | 10 | 40% | 3 |
7 | PILLAI, MR , BALARAM, P , CHIDAMBARAM, S , PADMANABHAN, TK , NAIR, MK , (1990) DEVELOPMENT OF AN IMMUNOLOGICAL STAGING SYSTEM TO PROGNOSTICATE DISEASE COURSE IN MALIGNANT CERVICAL NEOPLASIA.GYNECOLOGIC ONCOLOGY. VOL. 37. ISSUE 2. P. 200-205 | 9 | 90% | 13 |
8 | WILD, AT , HERMAN, JM , DHOLAKIA, AS , MONINGI, S , LU, Y , ROSATI, LM , HACKER-PRIETZ, A , ASSADI, RK , SAEED, AM , PAWLIK, TM , ET AL (2016) LYMPHOCYTE-SPARING EFFECT OF STEREOTACTIC BODY RADIATION THERAPY IN PATIENTS WITH UNRESECTABLE PANCREATIC CANCER.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 94. ISSUE 3. P. 571 -579 | 8 | 32% | 4 |
9 | PILLAI, MR , BALARAM, P , HAREENDRAN, NK , BINDU, S , PADMANABHAN, TK , NAIR, MK , (1990) CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF CONCANAVALIN-A-INDUCED SUPPRESSOR-CELL ACTIVITY IN MALIGNANT CERVICAL NEOPLASIA.BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY. VOL. 97. ISSUE 4. P. 357-361 | 8 | 89% | 2 |
10 | JURANIC, Z , VUCKOVICDEKIC, L , DURBABA, M , (1993) HUMORAL IMMUNITY IN PATIENTS WITH CARCINOMA OF THE UTERINE CERVIX - EFFECTS OF RADIATION-THERAPY.NEOPLASMA. VOL. 40. ISSUE 5. P. 297-300 | 7 | 88% | 2 |
Classes with closest relation at Level 1 |